We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Surgical Innovations Group Plc | LSE:SUN | London | Ordinary Share | GB0004016704 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.60 | 0.50 | 0.50 | 0.50 | 5,250,905 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 11.34M | 264k | 0.0003 | 16.67 | 4.66M |
TIDMSUN
RNS Number : 4163S
Surgical Innovations Group PLC
21 December 2016
Surgical Innovations Group plc
("SI Group" or the "Company")
Conversion of Loan Notes
& Issue of Shares
Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, announces the conversion of all of the outstanding unsecured fixed rate convertible loan notes ("Loan Notes") amounting to GBP1.00m, together with accrued interest of GBP0.11m into 44,259,178 ordinary shares of 1p each at a conversion price of 2.5p per share. The Loan Notes were originally created on 17 November 2014 and were repayable on 17 November 2017 unless converted into equity at an earlier date.
In addition, the Company has issued and allotted a total of 467,143 ordinary shares of 1p each ("Shares") at a price of 3.5p per share to Nigel Rogers, Executive Chairman, and Michael McMahon, Paul Hardy and Alistair Taylor, Non-Executive Directors.
Details of the Shares issued and the resulting holdings of each of the directors are as follows:
Director Shares Resulting Percentage issued holding of enlarged share capital Nigel Rogers 124,286 3,471,317 0.65% Michael McMahon 85,714 18,171,396 3.41% Paul Hardy * 142,857 3,561,474 0.67% Alistair Taylor 114,286 672,906 0.13%
* Paul Hardy's beneficial holding comprises the holdings of Hardy Transaction Management Limited, a company in which he has a controlling interest, and his SIPP
As the Shares have been issued in lieu of remuneration for the fourth quarter of 2016, the issue price was set at the closing price on the date of the Company's payroll in December.
Application will be made for 44,726,321 Shares to be admitted to trading on AIM ("Admission") which is expected to take place on 28 December 2016.
Following Admission, the total number of ordinary shares in issue will be 533,407,756 with each share carrying the right to one vote. The above figure may be used by shareholders as the denominator for the purposes of calculating their holding in the Company under the Disclosure Guidance and Transparency Rules.
For further information please contact:
Surgical Innovations Group www.sigroupplc.com plc Nigel Rogers, Executive Tel: 0113 230 7597 Chairman Melanie Ross, COO & Finance Director WH Ireland Limited (NOMAD Tel: 0113 394 6600 & Broker) Tim Feather/Ed Kennedy Walbrook PR (Financial PR Tel: 020 7933 8780 or & Investor Relations) si@walbrookpr.com Paul McManus Mob: 07980 541 893
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCAKKDDFBDDDBB
(END) Dow Jones Newswires
December 21, 2016 02:00 ET (07:00 GMT)
1 Year Surgical Innovations Chart |
1 Month Surgical Innovations Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions